CM
HAE icon

Caption Management’s Haemonetics HAE Stock Holding History

Caption Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200,000
Closed -$9.75M – 1781
2025
Q3 		$9.75M Buy
+200,000
New +$12.4M 0.08% 289
2025
Q1 		– Sell
-140,000
Closed -$10.9M – 1726
2024
Q4 		$10.9M Buy
140,000
+5,000
+4% +$402K 0.1% 172
2024
Q3 		$10.9M Buy
+135,000
New +$10.9M 0.17% 142
2022
Q3 		– Sell
-131,500
Closed -$8.57M – 1640
2022
Q2 		$8.57M Buy
+131,500
New +$7.78M 0.12% 219

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caption Management's HAE Position: Q1 2022 in Review

Caption Management sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 20,300 shares — an estimated $1.08M sold.

Caption Management first reported a position in HAE in Q4 2021 and held it in 1 quarter. The position peaked at $1.08M in Q4 2021. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

  • Caption Management reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
  • Caption Management sold 20,300 Haemonetics shares in Q1 2022, an estimated $1.08M.
  • Caption Management first reported a position in Haemonetics in Q4 2021 and held it in 1 quarter.
  • Caption Management's Haemonetics position peaked at $1.08M in Q4 2021.
  • 242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on Caption Management's 13F filing for Q1 2022, filed 13 May 2022.